These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20012397)

  • 1. Mouse models of type II diabetes mellitus in drug discovery.
    Baribault H
    Methods Mol Biol; 2010; 602():135-55. PubMed ID: 20012397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse Models of Type 2 Diabetes Mellitus in Drug Discovery.
    Baribault H
    Methods Mol Biol; 2016; 1438():153-75. PubMed ID: 27150090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
    Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
    Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
    Mustad VA; Demichele S; Huang YS; Mika A; Lubbers N; Berthiaume N; Polakowski J; Zinker B
    Metabolism; 2006 Oct; 55(10):1365-74. PubMed ID: 16979408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogenetic characteristics of enzyme activities and plasma metabolites in C57BL/6J:Jcl mice deficient in insulin receptor substrate 2.
    Hashimoto H; Arai T; Takeguchi A; Hioki K; Ohnishi Y; Kawai K; Ito M; Suzuki R; Yamauchi T; Ohsugi M; Saito M; Ueyama Y; Tobe K; Kadowaki T; Tamaoki N; Kosaka K
    Comp Med; 2006 Jun; 56(3):176-87. PubMed ID: 16774126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetaminophen normalizes glucose homeostasis in mouse models for diabetes.
    Shertzer HG; Schneider SN; Kendig EL; Clegg DJ; D'Alessio DA; Genter MB
    Biochem Pharmacol; 2008 Mar; 75(6):1402-10. PubMed ID: 18237716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel terpenoid-type quinones isolated from Pycnanthus angolensis of potential utility in the treatment of type 2 diabetes.
    Luo J; Cheung J; Yevich EM; Clark JP; Tsai J; Lapresca P; Ubillas RP; Fort DM; Carlson TJ; Hector RF; King SR; Mendez CD; Jolad SD; Reaven GM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):529-34. PubMed ID: 9918555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular targets for new drug discovery to treat type 2 diabetes and obesity].
    Bastarrachea RA; Montero JC; Saavedra-Gajardo I; Cerda-Flores R; Machado-Domínguez A; Comuzzie AG
    Rev Med Chil; 2008 Jan; 136(1):107-17. PubMed ID: 18483661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.
    Stefan N; Stumvoll M; Bogardus C; Tataranni PA
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1156-61. PubMed ID: 12582008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.
    Eriksson JG; Lehtovirta M; Ehrnström B; Salmela S; Groop L
    J Intern Med; 2006 Jun; 259(6):553-60. PubMed ID: 16704555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new type of orally active anti-diabetic Zn(II)-dithiocarbamate complex.
    Yoshikawa Y; Adachi Y; Sakurai H
    Life Sci; 2007 Jan; 80(8):759-66. PubMed ID: 17137606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes.
    Phillips JW; Barringhaus KG; Sanders JM; Yang Z; Chen M; Hesselbacher S; Czarnik AC; Ley K; Nadler J; Sarembock IJ
    Circulation; 2003 Oct; 108(16):1994-9. PubMed ID: 14517165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the progression of type 2 diabetes in the C57BL/6J mouse model by an anti-diabetes herbal formula.
    Winters WD; Huo YS; Yao DL
    Phytother Res; 2003 Jun; 17(6):591-8. PubMed ID: 12820223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interdependence of hepatic lipid and glucose metabolism: novel pharmacological targets for diabetes.
    Lind P
    Curr Opin Investig Drugs; 2004 Apr; 5(4):395-401. PubMed ID: 15134280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute starvation on insulin resistance in obese patients with and without type 2 diabetes mellitus.
    Duska F; Andel M; Kubena A; Macdonald IA
    Clin Nutr; 2005 Dec; 24(6):1056-64. PubMed ID: 16185788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptolepis sanguinolenta: an ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycaemic agent.
    Luo J; Fort DM; Carlson TJ; Noamesi BK; nii-Amon-Kotei D; King SR; Tsai J; Quan J; Hobensack C; Lapresca P; Waldeck N; Mendez CD; Jolad SD; Bierer DE; Reaven GM
    Diabet Med; 1998 May; 15(5):367-74. PubMed ID: 9609357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.
    Klein O; Lynge J; Endahl L; Damholt B; Nosek L; Heise T
    Diabetes Obes Metab; 2007 May; 9(3):290-9. PubMed ID: 17391154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus.
    Yoshikawa Y; Ueda E; Miyake H; Sakurai H; Kojima Y
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1190-3. PubMed ID: 11243860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.